JPMorgan Chase & Co’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $90.6K | Sell |
|
|||||
|
2025
Q2 | $114K | Buy |
|
|||||
|
2025
Q1 | $96K | Buy |
|
|||||
|
2024
Q4 | $87.6K | Buy |
|
|||||
|
2024
Q3 | $56.2K | Buy |
|
|||||
|
2024
Q2 | $52.8K | Buy |
|
|||||
|
2024
Q1 | $17.9K | Buy |
|
|||||
|
2023
Q4 | $8.93K | Buy |
|
|||||
|
2023
Q3 | $10.5K | Buy |
|
|||||
|
2023
Q2 | $10.9K | Sell |
|
|||||
|
2023
Q1 | $76K | Buy |
|
|||||
|
2022
Q4 | $123K | Buy |
|
|||||
|
2022
Q3 | $127K | Buy |
|
|||||
|
2022
Q2 | $140K | Buy |
|
|||||
|
2022
Q1 | $142K | Sell |
|
|||||
|
2021
Q4 | $344K | Sell |
|
|||||
|
2021
Q3 | $536K | Sell |
|
|||||
|
2021
Q2 | $1.13M | Sell |
|
|||||
|
2021
Q1 | $1.24M | Buy |
|
|||||
|
2020
Q4 | $803K | Buy |
|
|||||
|
2020
Q3 | $147K | Sell |
|
|||||
|
2020
Q2 | $165K | Buy |
|
|||||
|
2020
Q1 | $74K | Buy |
|
|||||
|
2019
Q4 | $96K | Buy |
|
|||||
|
2019
Q3 | $87K | Buy |
|
|||||
|
2019
Q2 | $64K | Buy |
|
|||||
|
2019
Q1 | $73K | Sell |
|
|||||
|
2018
Q4 | $82K | Buy |
|
|||||
|
2018
Q3 | $90K | Buy |
|
|||||
|
2018
Q2 | $78K | Sell |
|
|||||
|
2018
Q1 | $71K | Sell |
|
|||||
|
2017
Q4 | $73K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $226K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $5K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $178K | Buy |
|